Blue Owl Capital Holdings LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
74
Total Value
310078266
Accession Number
0000950123-25-005588
Form Type
13F-HR
Manager Name
Blue-Owl-Capital-Holdings-Lp
Data Enrichment
57% identified
42 identified32 unidentified

Holdings

74 positions
Manager:
Search and click to pin securities to the top
Page 1 of 4
Nuveen Churchill Direct Lending Corp.
Shares:4.0M
Value:$68.6M
Blue Owl Capital Corp
Shares:2.0M
Value:$30.0M
Cullinan Therapeutics, Inc.
Shares:2.4M
Value:$18.4M
EverCommerce Inc.
Shares:1.6M
Value:$16.6M
Tourmaline Bio, Inc.
Shares:1.0M
Value:$15.8M
CONDUENT Inc
Shares:5.7M
Value:$15.4M
29286M105
Shares:3.3M
Value:$14.7M
Holley Inc.
Shares:5.3M
Value:$13.7M
Larimar Therapeutics, Inc.
Shares:4.8M
Value:$10.3M
74347X831
Shares:175.0K
Value:$10.0M
17878Y207
Shares:348.2K
Value:$8.0M
Disc Medicine, Inc.
Shares:140.3K
Value:$7.0M
Eledon Pharmaceuticals, Inc.
Shares:1.8M
Value:$6.2M
Compass Therapeutics, Inc.
Shares:3.0M
Value:$5.6M
Ultragenyx Pharmaceutical Inc.
Shares:153.2K
Value:$5.5M
Ikena Oncology, Inc.
Shares:4.1M
Value:$5.2M
Centessa Pharmaceuticals plc
Shares:315.0K
Value:$4.5M
Context Therapeutics Inc.
Shares:7.4M
Value:$4.5M
Sagimet Biosciences Inc.
Shares:1.3M
Value:$4.3M
EyePoint Pharmaceuticals, Inc.
Shares:797.6K
Value:$4.3M